Literature DB >> 15095107

[Epitheliotrophic capacity of serum and plasma eyedrops. Influence of centrifugation].

P Herminghaus1, G Geerling, D Hartwig, T Wedel, L Dibbelt.   

Abstract

BACKGROUND: Serum eyedrops are a new modality for the treatment of ocular surface disorders. We examined the influence of the preparation of blood products in a cell culture model and compared it with plasma.
MATERIAL AND METHODS: Serum and plasma were obtained from full blood of ten healthy volunteers and centrifuged at 500 and 3000 G. EGF, PDGF, TGF-beta1, fibronectin, and vitamin A were quantified by means of ELISA and HPLC. Cultures of human corneal epithelial cells were incubated with the four blood products in dose-response experiments and the intracellular ATP quantified.
RESULTS: EGF, PDGF, and vitamin A were present in serum in significantly higher concentrations than in plasma. The concentration of fibronectin was not influenced by the preparation. Support of proliferation was best by 25% platelet-poor serum. Serum supported the differentiation and migration of epithelial cells better than plasma.
CONCLUSION: The biochemical character of serum eyedrops is determined by the parameters chosen to produce the blood product. Plasma does not seem to offer an epitheliotrophic capacity equivalent to serum eyedrops. Their production should be optimized before any meaningful randomized controlled clinical trial can be attempted.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15095107     DOI: 10.1007/s00347-003-0979-8

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  28 in total

1.  Cytokines and tear function in ocular surface disease.

Authors:  K Barton; A Nava; D C Monroy; S C Pflugfelder
Journal:  Adv Exp Med Biol       Date:  1998       Impact factor: 2.622

2.  [Autologous serum-eye-drops for ocular surface disorders. A literature review and recommendations for their application].

Authors:  G Geerling; D Hartwig
Journal:  Ophthalmologe       Date:  2002-12       Impact factor: 1.059

3.  Effects of aFGF and bFGF on wound healing in rabbit corneas.

Authors:  D Fredj-Reygrobellet; J Plouet; T Delayre; C Baudouin; F Bourret; P Lapalus
Journal:  Curr Eye Res       Date:  1987-10       Impact factor: 2.424

4.  Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies.

Authors:  A C Poon; G Geerling; J K Dart; G E Fraenkel; J T Daniels
Journal:  Br J Ophthalmol       Date:  2001-10       Impact factor: 4.638

5.  Decreased substance P concentrations in tears from patients with corneal hypesthesia.

Authors:  M Yamada; M Ogata; M Kawai; Y Mashima
Journal:  Am J Ophthalmol       Date:  2000-05       Impact factor: 5.258

6.  Advanced glycation end products in Descemet's membrane and their effect on corneal endothelial cell.

Authors:  Y Kaji; S Amano; T Usui; K Suzuki; S Tanaka; T Oshika; R Nagai; S Horiuchi
Journal:  Curr Eye Res       Date:  2001-12       Impact factor: 2.424

7.  Healing of corneal epithelial defects in plasminogen- and fibrinogen-deficient mice.

Authors:  W W Kao; C W Kao; A H Kaufman; K W Kombrinck; R L Converse; W V Good; T H Bugge; J L Degen
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-03       Impact factor: 4.799

8.  Treatment of persistent corneal epithelial defect by autologous serum application.

Authors:  K Tsubota; E Goto; S Shimmura; J Shimazaki
Journal:  Ophthalmology       Date:  1999-10       Impact factor: 12.079

9.  Epidermal growth factor and corneal wound healing. A multicenter study.

Authors:  J C Pastor; M Calonge
Journal:  Cornea       Date:  1992-07       Impact factor: 2.651

10.  The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix.

Authors:  B K Pilcher; J A Dumin; B D Sudbeck; S M Krane; H G Welgus; W C Parks
Journal:  J Cell Biol       Date:  1997-06-16       Impact factor: 10.539

View more
  7 in total

1.  [Chemical and thermal eye burns. Conservatíve and surgical options of a stage-dependent therapy].

Authors:  H G Struck; N F Schrage
Journal:  Ophthalmologe       Date:  2011-10       Impact factor: 1.059

2.  [Classification of biomedical research reports as a reference for evidence-based medicine in ophthalmology. A survey considering as example the journal Der Ophthalmologe].

Authors:  H P N Scholl; M Fleckenstein; T U Krohne; F G Holz
Journal:  Ophthalmologe       Date:  2005-12       Impact factor: 1.059

Review 3.  [Albumin eye drops for treatment of ocular surface diseases].

Authors:  J D Unterlauft; M Kohlhaas; I Hofbauer; K Kasper; G Geerling
Journal:  Ophthalmologe       Date:  2009-10       Impact factor: 1.059

4.  [Conservative and surgical treatment of neurotrophic keratopathy].

Authors:  B Seitz; M Grüterich; C Cursiefen; F E Kruse
Journal:  Ophthalmologe       Date:  2005-01       Impact factor: 1.059

Review 5.  Autologous serum eye drops for ocular surface disorders.

Authors:  G Geerling; S Maclennan; D Hartwig
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

6.  [Toxicity of a new moistening agent and preservative in vitro].

Authors:  K Kasper; C Kremling; G Geerling
Journal:  Ophthalmologe       Date:  2008-06       Impact factor: 1.059

Review 7.  [Autologous serum and alternative blood products for the treatment of ocular surface disorders].

Authors:  G Geerling; J D Unterlauft; K Kasper; S Schrader; A Opitz; D Hartwig
Journal:  Ophthalmologe       Date:  2008-07       Impact factor: 1.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.